Clinical Trials Browser

Unknown × INDUSTRY × Lymphoma, T-Cell × Clear all

NCT04712864 2023-10-03

Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma

Phase 1 Unknown

Lymphoma, T-Cell

NCT05557903 2022-09-28

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

Phase 1 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, T-Cell

NCT05398614 2022-06-01

SENL101 Autologous T Cell Injection in Adults With Relapsed or Refractory CD7+ Hematolymphoid Malignancies

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04928105 2022-05-31

Senl-T7 CAR-T Cells for Treatment of Relapsed or Refractory CD7+ Lymphoma

Phase NA Unknown

Lymphoma, T-Cell

NCT04162340 2021-05-19

CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

NCT03921879 2020-10-23

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Phase 1 Unknown

Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT02742727 2016-12-06

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Leukemia, Prolymphocytic, T-Cell, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma